Please login to the form below
pediatrics
This page shows the latest pediatrics news and features for those working in and with pharma, biotech and healthcare.
Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more
Orchard gains rare disease status for ex-GSK therapy. Orchard Therapeutics has been granted an FDA Rare Pediatric Disease Designation for its rare disease gene therapy candidate OTL-200, which it
Latest news
-
Dr Reddy's brings its generics portfolio to France
Meanwhile, in its home country it is targeting a number of therapy areas, having agreed a 118m deal with UCB in 2015 to acquire a portfolio of dermatology, respiratory and pediatric
-
Lilly pilots enhanced online trial information
The pilot project has so far been added to two clinical trials, a study of Taltz (ixekizumab) in non-radiographic axial spondyloarthritis and one of Cialis (tadalafil) in pediatric patients with
-
Biogen buys into Ionis' nusinersen after positive phase III trial
Potential blockbuster spinal muscular atrophy drug will be filed “in the coming months”
-
Celebrating excellence
The programme saw Novo work in partnership with Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the World Diabetes Foundation (WDF).
-
PMEA 2015 win for Novo's Changing Diabetes in Children
The programme saw Novo work in partnership with Roche, the International Society for Pediatric and Adolsecent Diabetes (ISPAD) and the World Diabetes Foundation (WDF).
More from news
Approximately 1 fully matching, plus 23 partially matching documents found.
Latest Intelligence
-
The trials and tribulations of rare opportunities
Preclinical trials of rare disease drugs are challenging, said Jeffrey Keefer, MD VP, Medical Strategy Head of Pediatric and Rare Disease at IQVIA.
-
Implementing eHealth innovation
The first results from the global, five-year observational study in children with growth disorders was presented at the 10th International Meeting of Pediatric Endocrinology in September 2017.
-
Paging Dr Millennial
Almost 50% of the world's population today is under 25 years old, which means that family planning, women's health and pediatrics will be growing elements of the world's
-
Pharma deals in August 2015
In 2012 the PRV programme was extended to include rare pediatric diseases and the emergence of trading in PRVs was noted in our last annual Deal Watch report.
-
Pharma deals during November 2014
In 2012 the PRV programme was extended to include rare pediatric diseases. ... BioMarin was awarded a Rare Pediatric Disease PRV when it received approval of Vimizim, a new biological product for patients with Mucopolysaccharidosis type IVA.
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest appointments
-
BMS appoints oncology development head
As a trained pediatric oncologist, Fouad brings to this role exceptional clinical experience and an unwavering commitment to patients.
-
Dr Andrew Mulberg moves from FDA to Amicus Therapeutics
Dr Mulberg is a pediatric gastroenterologist, and was attending physician and fellowship director in gastroenterology and hepatology for The Children's Hospital of Philadelphia between 1993 and 2001. ... He is currently the board chairman and member of
-
Former PEPFAR head Mark Dybul to lead the Global Fund
In addition to his new post, Dr Dybul currently serves as a director on several executive and advisory boards of health organisations, including Malaria No More, the Elizabeth Glaser Pediatric AIDS
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Mastering the precision medicine opportunity
Last year the FDA made a pioneering move in this space and approved Keytruda for use in adult and pediatric patients with unresectable or metastatic, microsatellite instability-high (MSI-H) or
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
Subscribe to our email news alerts
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Moving annual total (MAT)
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Leaked no-deal Brexit document forecasts widespread shortages
- FDA rejects Sarepta’s new Duchenne drug over safety fears
- Novo Nordisk shareholder revolt reaches Europe
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
